O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+4.94%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.01B
AUM Growth
+$8.01B
(+1.6%)
Cap. Flow
-$10.7B
Cap. Flow
% of AUM
-133.53%
Top 10 Holdings %
Top 10 Hldgs %
34.11%
Holding
150
New
16
Increased
29
Reduced
32
Closed
15
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$189M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$154M |
| 3 |
Tenet Healthcare
THC
|
$102M |
| 4 |
Merck
MRK
|
$90.6M |
| 5 |
DaVita
DVA
|
$71.4M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$10.7B |
| 2 |
Eli Lilly
LLY
|
$193M |
| 3 |
Elevance Health
ELV
|
$148M |
| 4 |
Amgen
AMGN
|
$145M |
| 5 |
Cigna
CI
|
$130M |
Sector Composition
| 1 | Healthcare | 95.15% |
| 2 | Financials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
26
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $102M | 1.27% |
1,884,100
+554,500
| +42% | +$30.1M |
|
|
27
Tenet Healthcare
THC
$16.5B
| $102M | 1.26% |
+4,189,300
| New | +$102M |
|
|
SHPG
28
DELISTED
Shire pic
SHPG
| $97.2M | 1.2% |
650,308
+377,800
| +139% | +$56.4M |
|
29
Iovance Biotherapeutics
IOVA
$800M
| $93.8M | 1.16% |
5,548,326
| – | – |
|
30
Universal Health Services
UHS
$11.6B
| $91.5M | 1.13% |
772,900
+598,100
| +342% | +$70.8M |
|
31
Select Medical
SEM
$1.6B
| $87.5M | 1.09% |
9,417,715
| – | – |
|
|
IMMU
32
DELISTED
Immunomedics Inc
IMMU
| $83.4M | 1.03% |
5,710,774
-2,750,953
| -33% | -$40.2M |
|
33
Thermo Fisher Scientific
TMO
$183B
| $80.4M | 1% |
389,400
| – | – |
|
|
ARRY
34
DELISTED
Array Biopharma Inc
ARRY
| $80M | 0.99% |
4,900,900
-2,720,500
| -36% | -$44.4M |
|
|
35
Amgen
AMGN
$153B
| $75.9M | 0.94% |
445,310
-851,790
| -66% | -$145M |
|
36
Viatris
VTRS
$12.3B
| $75.5M | 0.94% |
1,834,300
| – | – |
|
37
Acadia Pharmaceuticals
ACAD
$4.34B
| $75.1M | 0.93% |
3,340,700
+2,491,600
| +293% | +$56M |
|
38
Xtant Medical Holdings
XTNT
$82.4M
| $72.6M | 0.9% |
9,207,012
+8,810,813
| +2,224% | +$69.5M |
|
|
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $70.8M | 0.88% |
1,466,530
-691,200
| -32% | -$33.4M |
|
40
Corvus Pharmaceuticals
CRVS
$419M
| $68.8M | 0.85% |
5,967,584
+588,235
| +11% | +$6.78M |
|
41
Illumina
ILMN
$15.2B
| $67.3M | 0.83% |
292,466
-45,232
| -13% | -$10.4M |
|
42
Insmed
INSM
$30.3B
| $65.9M | 0.82% |
2,927,891
+1,431,100
| +96% | +$32.2M |
|
|
VRAY
43
DELISTED
ViewRay, Inc.
VRAY
| $60.8M | 0.75% |
9,458,567
| – | – |
|
|
MGLN
44
DELISTED
Magellan Health Services, Inc.
MGLN
| $60.4M | 0.75% |
563,843
-292,000
| -34% | -$31.3M |
|
45
Johnson & Johnson
JNJ
$429B
| $59.6M | 0.74% |
465,300
| – | – |
|
|
ONC
46
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.5B
| $59.6M | 0.74% |
354,900
-686,588
| -66% | -$115M |
|
|
BLUE
47
DELISTED
bluebird bio
BLUE
| $59M | 0.73% |
26,680
-2,968
| -10% | -$6.56M |
|
48
Rhythm Pharmaceuticals
RYTM
$6.75B
| $57.7M | 0.72% |
2,901,295
| – | – |
|
49
KALA BIO
KALA
$105M
| $54.6M | 0.68% |
69,026
+21,473
| +45% | +$17M |
|
50
Galapagos
GLPG
$2.06B
| $48.6M | 0.6% |
486,990
| – | – |
|